German specialists treating testicular cancer follow different guidelines with resulting inconsistency in assessment of retroperitoneal lymph-node metastasis: clinical implications and possible corrective measures

1

Testicular germ cell tumors (GCTs) have a rising incidence and are the most common cancer in young males, with survival rates varying by disease stage.
2

Current guidelines for GCT treatment lack consistency in assessing retroperitoneal lymph-node metastasis, leading to potential misclassification.
3

A survey of German specialists revealed significant discrepancies in measuring lymph-node size, with varying preferences for short-axis and long-axis diameters.
4

Only 17% of urologists and none of the oncologists included calculated lymph-node volume in their assessments of clinical staging or residual mass.
5

The study highlights the need for standardized guidelines and practices to improve the accuracy of GCT staging and treatment decisions.

World Journal Of Urology

by Justine Schoch, Kathrin Haunschild, Angelina Strauch, Kai Nestler, Hans Schmelz, Pia Paffenholz, David Pfister, Thorsten Persigehl, Axel Heidenreich, Tim Nestler
April 4, 2023

1